AAAAAA

   
Results: 1-8 |
Results: 8
Repair of femoral postcatheterization pseudoaneurysm and arteriovenous fistula with percutaneous implantation of endovascular stent
Authors: Brummer, U Salcuni, M Salvati, F Bonomini, M
Citation: U. Brummer et al., Repair of femoral postcatheterization pseudoaneurysm and arteriovenous fistula with percutaneous implantation of endovascular stent, NEPH DIAL T, 16(8), 2001, pp. 1728-1729
Response to recombinant human erythropoietin (rHu-Epo) in a patient with chronic renal failure and myelomonocytic leukaemia
Authors: Salvati, F Liani, M Bonomini, M
Citation: F. Salvati et al., Response to recombinant human erythropoietin (rHu-Epo) in a patient with chronic renal failure and myelomonocytic leukaemia, NEPH DIAL T, 16(1), 2001, pp. 191-192
Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis
Authors: Salvati, F Liani, M
Citation: F. Salvati et M. Liani, Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis, INT J ARTIF, 24(3), 2001, pp. 131-135
Managing patients with lung cancer - Common international guidelines must be developed
Authors: Ardizzoni, A Grossi, F Salvati, F Silvano, G Santi, L
Citation: A. Ardizzoni et al., Managing patients with lung cancer - Common international guidelines must be developed, BR MED J, 320(7231), 2000, pp. 380-380
Phase III comparative study of high-dose cisplatin versus a combination ofpaclitaxel and cisplatin in patients with advanced non-small-cell lung cancer
Authors: Gatzemeier, U von Pawel, J Gottfried, M ten Velde, GPM Mattson, K DeMarinis, F Harper, P Salvati, F Robinet, G Lucenti, A Bogaerts, J Gallant, G
Citation: U. Gatzemeier et al., Phase III comparative study of high-dose cisplatin versus a combination ofpaclitaxel and cisplatin in patients with advanced non-small-cell lung cancer, J CL ONCOL, 18(19), 2000, pp. 3390-3399
Ambamustine in the second-line treatment of patients with small-cell lung cancer - A phase II Fonicap study
Authors: Ardizzoni, A Antonelli, G Ricci, S Frasci, G Rinaldi, M Boni, L Galletti, P Pennucci, MC Antonuzzo, A Gravina, A Galli, L Comella, G Conte, PF Salvati, F Rosso, R
Citation: A. Ardizzoni et al., Ambamustine in the second-line treatment of patients with small-cell lung cancer - A phase II Fonicap study, AM J CL ONC, 23(1), 2000, pp. 22-25
Treatment of inoperable non-small cell lung carcinoma stage IIIb and IV with cisplatin, epidoxorubicin, vindesine and lonidamine: A phase II study
Authors: Portalone, L Lombardi, A Antilli, A Cruciani, AR Magliacani, V Mugnaini, L Nunziati, F Perrone, N Signora, M Salvati, F
Citation: L. Portalone et al., Treatment of inoperable non-small cell lung carcinoma stage IIIb and IV with cisplatin, epidoxorubicin, vindesine and lonidamine: A phase II study, TUMORI, 85(4), 1999, pp. 239-242
The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: A phase III randomized FONICAP trial
Authors: De Marinis, F Rinaldi, M Ardizzoni, A Bruzzi, P Pennucci, MC Portalone, L D'Aprile, M Ripanti, P Romano, F Belli, M Altavilla, G Migliorino, MR Rosso, R Salvati, F
Citation: F. De Marinis et al., The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: A phase III randomized FONICAP trial, TUMORI, 85(3), 1999, pp. 177-182
Risultati: 1-8 |